REPLACE DARE Risk Score Calculator
Patient variables
Select the option that best matches the patient's clinical status.
About the REPLACE DARE score
The REPLACE DARE (Death After Replacement Evaluation) score was developed to help estimate 6-month all-cause mortality after cardiac implantable electronic device (CIED) replacement or upgrade. The original registry study identified clinical factors associated with mortality; major complications were not significantly associated with death in that analysis.
Variables represented in this calculator
| Variable | Options used in this form |
|---|---|
| Recent heart-failure admission | No; Yes |
| NYHA functional class | Class I/II; Class III/IV |
| Chronic kidney disease stage | Stage 1; Stage 2; Stage 3; Stage 4; Stage 5 |
| Anti-arrhythmic drug use | No; Yes |
| Cerebrovascular disease history | No; Yes |
| Age group | Under 60 years; 60–69 years; 70–79 years; 80 years or older |
Evidence reported in the publication
- Registry population: 1,744 patients; 70 deaths (4.0%) by 6 months.
- Discrimination: ROC area 0.758 (P < 0.001).
- Reported mortality: 1.0% at DARE = 0 and 55.6% at DARE = 7.
- Reported hazard ratio: 1.8 for each one-unit change in DARE score.
Reference
Chung MK, Holcomb RG, Mittal S, et al. REPLACE DARE (Death After Replacement Evaluation) Score: Determinants of All-Cause Mortality After Implantable Device Replacement or Upgrade from the REPLACE Registry. Circulation: Arrhythmia and Electrophysiology. 2014;7(6):1048–1056.
DOI: 10.1161/CIRCEP.114.001671
PMID: 25221331
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.